1、33个产品,三种规格:1mg,2mg,5mg; 2、价格优,全现货; 3、科研产品,仅用科研,禁用临床; Supplier供应商:BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心 电话:010-53513060 网址http://www.biovector.net 在线咨询 您正在向biovector.net发送关于产品阿维鲁单抗Avelumab (anti-PDL-1) 1537032-82-8的询问...
Anti-PDL-1 monoclonal antibodies or antigen-binding fragments thereof are disclosed. Invention also discloses a nucleic acid molecule, an expression vector, a host cell, a method for producing the antibody and a hybridoma cell strain. In addition, a conjugate, a bifunctional conjugate and a ...
pDHtskpEnCMVpCS2pEF人肥大细胞BB170哈维氏弧菌 注册/登录 pET9a-anti-PDL1-Nanobody 平台编号:zl-001697 相关信息:大肠杆菌 注意事项:仅用于科学研究或者工业应用等非医疗目的不可用于人类或动物的临床诊断或治疗,非药用,非食用(产品信息以出库为准) 详情描述 ...
免费查询更多anti pdl1 亲和力试剂盒详细参数、实时报价、行情走势、优质商品批发/供应信息等,您还可以发布询价信息。
PET9A-ANTI-PDL1-NANOBODY 中文别名: PET9A-ANTI-PDL1-NANOBODY CBNumber: CB813296786 分子式: 分子量: 0 MOL File: Mol file 化学性质安全信息用途供应商1 PET9A-ANTI-PDL1-NANOBODY化学性质 安全信息 PET9A-ANTI-PDL1-NANOBODY性质、用途与生产工艺 ...
抗体名:Anti PDL1 mouse monoclonal antibody 浓度:1mg/ml % 宿主:Mouse 用途:科研实验 应用范围:Elisa,WB,flow,IHC 产地:中国 品牌:chemstan 货号:CS10056Mo 用途:科研实验 保质期:一年 包装规格:100ul 保存条件:Stable for one year at -20°C
anti-PDL1给药组肿瘤抑制效果更明显,而两药联合组肿瘤抑制作用比单药给药组更强.结论:SFI抑制黑色素瘤亚油酸代谢了下游D6D酶蛋白的表达,COX-2酶活性和炎症因子PGE2的生成,进而抑制了MDSCs细胞的增殖,促进了CD8+T细胞,CD4+T细胞的增殖和活性,减少了Tregs细胞的浸润,从而达到抗肿瘤作用.并且SFI联合anti-PDL1具有...
Here we study the combination of Socazolimab, an anti-PDL1 antibody, carboplatin and etoposide to treat extensive stage small cell lung cancer.Methods:The study is a randomized, double-blinded, placebo-controlled multicenter Phase III clinical trial. Patients who have extensive-stage SCLC are ...
关键字: Anti-SPDL1 Polyclonal Antibody;抗体 公司简介 北京索莱宝科技有限公司是一家集研发、生产、销售、服务于一体的高科技生物企业。技术推广;技术转让;技术咨询;技术服务;生物试剂技术开发;销售生物试剂盒、实验室专用化学试剂、实验室专用设备、办公用品、化工产品(不含危险化学品)、计算机软件及辅助设备;货物...
Most antibodies directed against PD-1/PD-L1 are of the IgG4 isotype, or of the IgG1 isotype engineered with an Fc domain mutation to impair antibody dependent cellular cytotoxicity (ADCC) activity. Multiple anti-cancer MAbs, such as anti-CTLA4 (ipilimumab), anti-CD20 (rituximab), anti-HER2...